10-71741862-C-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM1BP4_ModerateBS1_Supporting

The NM_022124.6(CDH23):​c.4786C>T​(p.Arg1596Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000509 in 1,610,716 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1596H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000043 ( 1 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

2
4
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2B:1

Conservation

PhyloP100: 2.93

Publications

6 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
CDH23 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_022124.6
BP4
Computational evidence support a benign effect (MetaRNN=0.25279945).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000425 (62/1458464) while in subpopulation MID AF = 0.00208 (12/5764). AF 95% confidence interval is 0.0012. There are 1 homozygotes in GnomAdExome4. There are 32 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.4786C>T p.Arg1596Cys missense_variant Exon 38 of 70 ENST00000224721.12 NP_071407.4 Q9H251-1Q6P152

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.4786C>T p.Arg1596Cys missense_variant Exon 38 of 70 5 NM_022124.6 ENSP00000224721.9 Q9H251-1
CDH23ENST00000398792.3 linkn.1475C>T non_coding_transcript_exon_variant Exon 9 of 9 2

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152252
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.0000291
AC:
7
AN:
240566
AF XY:
0.00000763
show subpopulations
Gnomad AFR exome
AF:
0.000414
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000566
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000425
AC:
62
AN:
1458464
Hom.:
1
Cov.:
33
AF XY:
0.0000441
AC XY:
32
AN XY:
725250
show subpopulations
African (AFR)
AF:
0.00105
AC:
35
AN:
33426
American (AMR)
AF:
0.00
AC:
0
AN:
44404
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26018
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39618
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85554
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52666
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1110774
Other (OTH)
AF:
0.000116
AC:
7
AN:
60240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152252
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.000386
AC:
16
AN:
41466
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68042
Other (OTH)
AF:
0.000955
AC:
2
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000107
Hom.:
0
Bravo
AF:
0.000189
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000459
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000413
AC:
5
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Oct 10, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 12 Pathogenic:1
Jan 06, 2024
Wonkam Laboratory, Johns Hopkins University
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

This variant CDH23 c.4786C>T (NM_022124.5) is predicted to lead to a missense mutation that is absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium PM2). The variant segregated with multiple individuals with hearing impairment for a gene known to cause the phenotype being investigated (PP1), patient's phenotype and family history is highly specific for a disease with single origin (PP4). -

not specified Uncertain:1
Oct 11, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Arg1596Cys variant in CDH23 has not been previously reported in individual s with hearing loss, but has been identified in 4/6868 of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s372636295). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational predi ction tools suggest that the variant may impact the protein, though this informa tion is not predictive enough to assume pathogenicity. In summary, the clinical significance of the p.Arg1596Cys variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.21
T;D
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.94
D;D
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.25
T;T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
2.0
.;M
PhyloP100
2.9
PrimateAI
Benign
0.23
T
REVEL
Benign
0.22
Sift4G
Pathogenic
0.0010
D;.
Polyphen
0.99
.;D
Vest4
0.65
MVP
0.77
ClinPred
0.35
T
GERP RS
5.1
Varity_R
0.13
gMVP
0.51
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372636295; hg19: chr10-73501619; API